Indofarma Tbk. vs Kentanix Supra International Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Kentanix Supra International Tbk. trades at Rp406 (market cap 867.96B, 81.6K 24h volume). The key difference: Kentanix Supra International Tbk. is far larger — about 2.2× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | KSIX | |
|---|---|---|
Market Cap | 390.51B | 867.96B |
Volume | — | 81.6K |
Lot | — | 816 |
Turnover | — | 33.19M |
Average Price | — | 406.78 |
Value | — | 33.19M |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.
Read more on KSIX →